POINT Biopharma Global Inc. (PNT) reported Q3 EPS of ($0.86), versus ($0.75) reported last year. Revenue for the quarter came in at $869.7 thousand, versus $159.5 thousand reported last year.
POINT Biopharma Global Inc. (PNT) reported Q3 EPS of ($0.86), versus ($0.75) reported last year. Revenue for the quarter came in at $869.7 thousand, versus $159.5 thousand reported last year.